Literature DB >> 34162261

Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.

Zi Wang1,2,3, Zhiying Li1,2,3, Suping Luo1,2,3, Zhikai Yang1,2,3, Ying Xing4, Chengwei Pu4, Jie Dong1,2,3.   

Abstract

Eosinophilic peritonitis (EP) is a well-described complication of peritoneal dialysis that occurs because of an overreaction to constituents that are related to the catheter or tubing, peritoneal dialysate, pathogenic infection, or intraperitoneal drug use. EP caused by antibiotic use is rare. We present the case of a patient with cefoperazone and sulbactam-related EP. A 59-year-old woman who was undergoing peritoneal dialysis presented with peritonitis with abdominal pain and turbid peritoneal dialysis. Empiric intraperitoneal cefazolin in combination with cefoperazone and sulbactam was started after peritoneal dialysis effluent cultures were performed. Her peritonitis achieved remission in 2 days with the help of cephalosporin, but she developed EP 1 week later, when her dialysate eosinophil count peaked at 49% of the total dialysate white blood cells (absolute count, 110/mm3). We excluded other possible causes and speculated that cefoperazone and sulbactam was the probable cause of EP. The patient continued treatment with cefoperazone and sulbactam for 14 days. EP resolved within 48 hours after stopping cefoperazone and sulbactam. Thus, EP can be caused by cefoperazone and sulbactam use. Physicians should be able to distinguish antibiotic-related EP from refractory peritonitis to avoid technique failure.

Entities:  

Keywords:  Cefoperazone; adverse effect; cephalosporin; eosinophilic peritonitis; peritoneal dialysis; refractory peritonitis; sulbactam

Year:  2021        PMID: 34162261     DOI: 10.1177/03000605211025367

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  1 in total

1.  Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to Stay-Safe Balance solution: a case report.

Authors:  Zi Chan; Yun Ho Hui; Sunny Sze Ho Wong
Journal:  BMC Nephrol       Date:  2022-04-18       Impact factor: 2.585

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.